Skip to main content
SpringerLink
Log in

The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review

  • Review
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

Attention-deficit hyperactivity disorder (ADHD) is typically diagnosed using clinical observation and subjective informant reports. Once children commence ADHD medication, robust monitoring is required to detect partial or non-responses. The extent to which neuropsychological continuous performance tests (CPTs) and objective measures of activity can clinically aid the assessment and titration process in ADHD is not fully understood. This review describes the current evidence base for the use of CPTs and objectively measured activity to support the diagnostic procedure and medication management for children with ADHD. Four databases (PsycINFO, Medline, Allied and Complementary Medicine (AMED), and PsycARTICLES) were systematically searched to understand the current evidence base for (1) the use of CPTs to aid clinical assessment of ADHD; (2) the use of CPTs to aid medication management; and (3) the clinical utility of objective measures of activity in ADHD. Sixty relevant articles were identified. The search revealed six commercially available CPTs that had been reported on for their clinical use. There were mixed findings with regard to the use of CPTs to assess and manage medication, with contrasting evidence on their ability to support clinical decision-making. There was a strong evidence base for the use of objective measures of activity to aid ADHD/non-ADHD group differentiation, which appears sensitive to medication effects and would also benefit from further research on their clinical utility. The findings suggest that combining CPTs and an objective measure of activity may be particularly useful as a clinical tool and worthy of further pursuit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Notes

  1. Excluding an erratum to the Rielly et al. article [27], the correct specificity figures were obtained from the Rielly et al. erratum [28].

References

  1. NICE (2008) Attention deficit hyperactivity disorder:diagnosis and managment of ADHD in children, young people and adults. Clin Guidel 72. In: National Institute for Health and Clinical Excellence, London

  2. Magyary D, Brandt P (2002) A decision tree and clinical paths for the assessment and management of children with ADHD. Issues Ment Health Nurs 23:553–566

    Article  PubMed  Google Scholar 

  3. Faraone SV, Biederman J (1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiat 44:951–958

    Article  CAS  PubMed  Google Scholar 

  4. Ogundele MO, Ayyash HF, Banerjee S (2011) Role of computerised continuous performance task tests in ADHD. Prog Neural Psychiatr 15:8–13

    Article  Google Scholar 

  5. Weinberg WA, Brumback RA (1992) The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurol 7:431–445

    Article  CAS  PubMed  Google Scholar 

  6. Hall CL, Walker GM, Valentine AZ, Guo B, Kaylor-Hughes C, James M, Daley D, Sayal K, Hollis C (2014) Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD—‘Assessing QbTest Utility in ADHD’(AQUA): a randomised controlled trial. BMJ Open 4:e006838

    Article  PubMed  PubMed Central  Google Scholar 

  7. Epstein JN, Erkanli A, Conners CK, Klaric J, Costello JE, Angold A (2003) Relations between continuous performance test performance measures and ADHD behaviors. J Abnorm Child Psychol 31:543–554

    Article  PubMed  Google Scholar 

  8. Losier BJ, McGrath PJ, Klein RM (1996) Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 37:971–987

    Article  CAS  PubMed  Google Scholar 

  9. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001) Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13:326–335

    Article  CAS  PubMed  Google Scholar 

  10. Dupuy T, Greenberg L (1993) TOVA manual for test of variables of attention computer program. University of Minnesota, Minneapolis

    Google Scholar 

  11. Conners C (1995) The Conners Rating Scales: instruments for the assessment of childhood psychopathology. Duke University, Durham

    Google Scholar 

  12. Gordon M (1982) The Gordon diagnostic system. Gordon Systems, New York

    Google Scholar 

  13. Vogt C, Williams T (2011) Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with hyperkinetic disorder. Child Adolesc Ment Health 16:144–149

    Article  Google Scholar 

  14. McGee RA, Clark SE, Symons DK (2000) Does the Conners’ continuous performance test aid in ADHD diagnosis? J Abnorm Child Psychol 28:415–424

    Article  CAS  PubMed  Google Scholar 

  15. Lis S, Baer N, Stein-en-Nosse C, Gallhofer B, Sammer G, Kirsch P (2010) Objective measurement of motor activity during cognitive performance in adults with attention-deficit/hyperactivity disorder. Acta Psychiat Scand 122:285–294

    Article  PubMed  Google Scholar 

  16. Chae PK, Kim J-H, Noh K-S (2003) Diagnosis of ADHD among gifted children in relation to KEDI-WISC and T.O.V.A. performance. Gift Child Q 47:192–201

    Article  Google Scholar 

  17. Mayes S, Calhoun L, Crowell EW (2001) Clinical validity and interpretation of the Gordon diagnostic system in ADHD assessments. Child Neuropsychol 7:32–41

    Article  Google Scholar 

  18. Wang L-J, Huang Y-S, Chiang Y-L, Hsiao C-C, Shang Z-Y, Chen C-K (2011) Clinical symptoms and performance on the continuous performance test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months. BMC Psychiatry 11:65

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kim J, Lee Y, Han D, Min K, Kim D, Lee C (2015) The utility of quantitative electroencephalography and integrated visual and auditory continuous performance test as auxiliary tools for the attention deficit hyperactivity disorder diagnosis. Clin Neurophysiol 126:532–540

    Article  PubMed  Google Scholar 

  20. Ulberstad F (2012) QbTest technical manual. Qbtech AB, Stockholm

    Google Scholar 

  21. Tabori-Kraft J, Sørensen MJ, Kærgaard M, Dalsgaard S, Thomsen PH (2007) Is OPTAx™ useful for monitoring the effect of stimulants on hyperactivity and inattention? Eur Child Adolesc Psychiatry 16:347–351

    Article  PubMed  Google Scholar 

  22. Porumb M (2007) Using T.O.V.A. for the assessment of ADHD: a case study. Cogn Creier Comport 11:571–584

    Google Scholar 

  23. Preston AS, Fennell EB, Bussing R (2005) Utility of a CPT in diagnosing ADHD among a representative sample of high-risk children: a cautionary study. Child Neuropsychol 11:459–469

    Article  PubMed  Google Scholar 

  24. Schatz AM, Ballantyne AO, Trauner DA (2001) Sensitivity and specificity of a computerized test of attention in the diagnosis of attention-deficit/hyperactivity disorder. Assessment 8:357–365

    Article  CAS  PubMed  Google Scholar 

  25. Wada N, Yamashita Y, Matsuishi T, Ohtani Y, Kato H (2000) The test of variables of attention (TOVA) is useful in the diagnosis of Japanese male children with attention deficit hyperactivity disorder. Brain Dev 22:378–382

    Article  CAS  PubMed  Google Scholar 

  26. Forbes GB (1998) Clinical utility of the test of variables of attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol 54:461–476

    Article  CAS  PubMed  Google Scholar 

  27. Rielly NE, Cunningham CE, Richards JE, Elbard HJ, MAhoney WJ (1999) Detecting attention deficit hyperactivity disorder in a communications clinic: diagnostic utility of the gordon diagnostic system. J Clin Exp Neuropsycol 21:685–700

    Article  CAS  Google Scholar 

  28. Rielly NE, Cunningham CE, Richards JE, Elbard H, Mahoney WJ (2000) Detecting attention deficit hyperactivity disorder in a communications clinic: diagnostic utility of the gordon diagnostic system. J Clin Exp Neuropsycol 22:435

    Article  Google Scholar 

  29. DuPaul GJ, Anastopoulos AD, Shelton TL, Guevremont DC, Metevia L (1992) Multimethod assessment of attention-deficit hyperactivity disorder: the diagnostic utility of clinic-based tests. J Clin Child Psychol 21:394–402

    Article  Google Scholar 

  30. Maye Mayes S, Calhoun SL (2002) The gordon diagnostic system and WISC-III Freedom from Distractibility Index: validity in identifying clinic-referred children with and without ADHD. Psychol Rep 91:575–587

    Article  Google Scholar 

  31. Gordon M (1986) How is a computerized attention test used in the diagnosis of attention deficit disorder? J Child Contemp Soc 19:53–64

    Article  Google Scholar 

  32. El-Sayed E, Van’t Hooft I, Fried I, Larsson JO, Malmberg K, Rydelius PA (1999) Measurements of attention deficits and impulsivity: a Swedish study of the gordon diagnostic system. Acta Paediatr 88:1262–1268

    Article  CAS  PubMed  Google Scholar 

  33. Mayes SD, Calhoun SL, Chase GA, Mink DM, Stagg RE (2009) ADHD subtypes and co-occurring anxiety, depression, and oppositional-defiant disorder: differences in gordon diagnostic system and Wechsler Working Memory and Processing Speed Index scores. J Atten Disord 12:540–550

    Article  PubMed  Google Scholar 

  34. Trommer BL, Hoeppner J-AB, Lorber R, Armstrong K (1988) Pitfalls in the use of a continuous performance test as a diagnostic tool in attention deficit disorder. J Dev Behav Pediatr 9:339–345

    Article  CAS  PubMed  Google Scholar 

  35. Matier-Sharma K, Perachio N, Newcorn JH, Sharma V, Halperin JM (1995) Differential diagnosis of ADHD: are objective measures of attention, impulsivity, and activity level helpful? Child Neuropsychol 1:118–127

    Article  Google Scholar 

  36. Barkley RA, Grodzinsky G (1994) Are tests of frontal lobe functions useful in the diagnosis of attention deficit disorders? Clin Neuropsychol 8:121–139

    Article  Google Scholar 

  37. Grodzinsky GM, Barkley RA (1999) Predictive power of frontal lobe tests in the diagnosis of attention deficit hyperactivity disorder. Clin Neuropsychol 13:12–21

    Article  CAS  PubMed  Google Scholar 

  38. Alloway TP, Gathercole SE, Holmes J, Place M, Elliott JG, Hilton K (2009) The diagnostic utility of behavioral checklists in identifying children with ADHD and children with working memory deficits. Child Psychiat Hum Dev 40:353–366

    Article  Google Scholar 

  39. Perugini EM, Harvey EA, Lovejoy DW, Sandstrom K, Webb AH (2000) The predictive power of combined neuropsychological measures for attention-deficit/hyperactivity disorder in children. Child Neuropsychol 6:101–114

    Article  CAS  PubMed  Google Scholar 

  40. Kleinman A, Caetano SC, Brentani H, de Almeida Rocca CC, Dos Santos B, Andrade ER, Zeni CP, Tramontina S, Rohde LAP, Lafer B (2015) Attention-based classification pattern, a research domain criteria framework, in youths with bipolar disorder and attention-deficit/hyperactivity disorder. Aust N Z J Psychiatry. doi:10.1177/0004867414557957

    PubMed  Google Scholar 

  41. Vogt C, Shameli A (2011) Assessments for attention-deficit hyperactivity disorder: use of objective measurements. Psychiatrist 35:380–383

    Article  Google Scholar 

  42. Aggarwal A, Lillystone D (2000) A follow-up pilot study of objective measures in children with attention deficit hyperactivity disorder. J Paediatr Child Health 36:134–138

    Article  CAS  PubMed  Google Scholar 

  43. Manor I, Meidad S, Zalsman G, Zemishlany Z, Tyano S, Weizman A (2008) Objective versus subjective assessment of methylphenidate response. Child Psychiat Hum Dev 39:273–282

    Article  Google Scholar 

  44. Huang Y-S, Chao C-C, Wu Y-Y, Chen Y-Y, Chen C-K (2007) Acute effects of methylphenidate on performance during the test of variables of attention in children with attention deficit/hyperactivity disorder. Psychiat Clin Neurosci 61:219–225

    Article  CAS  Google Scholar 

  45. Wang L-J, Chen C-K, Huang Y-S (2015) Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate. J Child Adolesc Psychopharmacol 25:246–253

    Article  PubMed  Google Scholar 

  46. Fernandez-Jaen A, Fernandez-Mayoralas DM, Pardos A, Calleja-Perez B, Munoz Jareno N (2009) Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation. Adv Ther 26:1097–1110

    Article  PubMed  Google Scholar 

  47. Bédard ACV, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH (2015) Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry 56:40–48

    Article  PubMed  Google Scholar 

  48. Teicher MH, Polcari A, McGreenery CE (2008) Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 18:265–270

    Article  PubMed  PubMed Central  Google Scholar 

  49. Fischer M (1991) Assessment of stimulant response in ADHD children using a refined multimethod clinical protocol. J Clin Child Psychol 25:121

    Google Scholar 

  50. Greenberg L (1986) An objective measure of methylphenidate response: clinical use of the MCA. Psychopharmacol Bull 23:279–282

    Google Scholar 

  51. Teicher MH, Ito Y, Glod CA, Barber NI (1996) Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 35:334–342

    Article  CAS  PubMed  Google Scholar 

  52. Teicher MH (1995) Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry 3:18–35

    Article  CAS  PubMed  Google Scholar 

  53. Alderson RM, Rapport MD, Kasper LJ, Sarver DE, Kofler MJ (2012) Hyperactivity in boys with attention deficit/hyperactivity disorder (ADHD): the association between deficient behavioral inhibition, attentional processes, and objectively measured activity. Child Neuropsychol 18:487–505

    Article  PubMed  Google Scholar 

  54. Dane AV, Schachar RJ, Tannock R (2000) Does actigraphy differentiate ADHD subtypes in a clinical research setting? J Am Acad 39:752–760

    Article  CAS  Google Scholar 

  55. Wood AC, Asherson P, Rijsdijk F, Kuntsi J (2009) Is overactivity a core feature in ADHD? Familial and receiver operating characteristic curve analysis of mechanically assessed activity level. J Am Acad Child Psychiatry 48:1023–1030

    Article  Google Scholar 

  56. Halperin JM, Matier K, Bedi G, Sharma V, Newcorn JH (1992) Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder. J Am Acad Child Psychiatry 31:190–196

    Article  CAS  Google Scholar 

  57. Inoue K, Nadaoka T, Oiji A, Morioka Y, Totsuka S, Kanbayashi Y, Hukui T (1998) Clinical evaluation of attention-deficit hyperactivity disorder by objective quantitative measures. Child Psychiat Hum Dev 28:179–188

    Article  CAS  Google Scholar 

  58. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE Jr (1983) A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 40:681–687

    Article  CAS  PubMed  Google Scholar 

  59. Halperin JM, Newcorn JH, Matier K, Sharma V, McKAY KE, Schwartz S (1993) Discriminant validity of attention-deficit hyperactivity disorder. J Am Acad Child Psychiatry 32:1038–1043

    Article  CAS  Google Scholar 

  60. Hall S, Halperin J, Schwartz S, Newcorn J (1997) Behavioral and executive functions in children with attention-deficit hyperactivity disorder and reading disability. J Atten Disord 1:235–243

    Article  Google Scholar 

  61. Marks DJ, Himelstein J, Newcorn JH, Halperin JM (1999) Identification of AD/HD subtypes using laboratory-based measures: a cluster analysis. J Abnorm Child Psychol 27:167–175

    Article  CAS  PubMed  Google Scholar 

  62. Rajendran K, O’Neill S, Marks DJ, Halperin JM (2015) Latent profile analysis of neuropsychological measures to determine preschoolers’ risk for ADHD. J Child Psychol Psychiatry. doi:10.1111/jcpp.12434

    Google Scholar 

  63. Rapoport JL, Tepsic PN, Grice J, Johnson C, Langer D (1980) Decreased motor activity of hyperactive children on dextroamphetamine during active gym program. Psychiat Res 2:225–229

    Article  CAS  Google Scholar 

  64. Konrad K, Gunther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B (2005) Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc Psychopharmacol 15:180–190

    Article  PubMed  Google Scholar 

  65. Borcherding BG, Keysor CS, Cooper TB, Rapoport JL (1989) Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children. Neuropsychopharmacol 2:255–263

    Article  CAS  Google Scholar 

  66. Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL (1989) Fenfluramine and dextroamphetamine treatment of childhood hyperactivity: clinical and biochemical findings. Arch Gen Psychiat 46:205–212

    Article  CAS  PubMed  Google Scholar 

  67. Porrino LJ, Rapoport JL, Behar D, Ismond DR, Bunney WE (1983) A naturalistic assessment of the motor activity of hyperactive boys: II. Stimulant drug effects. Arch Gen Psychiat 40:688–693

    Article  CAS  PubMed  Google Scholar 

  68. De Crescenzo F, Armando M, Mazzone L, Ciliberto M, Sciannamea M, Figueroa C, Janiri L, Quested D, Vicari S (2014) The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis. ADHD Atten Defic Hyperact Disord 6:49–58

    Article  PubMed  Google Scholar 

  69. O’Mahony N, Florentino-Liano B, Carballo JJ, Baca-García E, Rodríguez AA (2014) Objective diagnosis of ADHD using IMUs. Med Eng Phys 36:922–926

    Article  PubMed  Google Scholar 

  70. Reh V, Schmidt M, Lam L, Schimmelmann BG, Hebebrand J, Rief W, Christiansen H (2013) Behavioral assessment of core ADHD symptoms using the QbTest. J Atten Disord. doi:10.1177/1087054712472981

    Google Scholar 

  71. Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier P, Hebebrand J, Remschmidt H (2004) Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry 13:100–104

    Article  CAS  PubMed  Google Scholar 

  72. Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T (2011) Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. J Child Adolesc Psychopharmacol 21:433–444

    Article  CAS  PubMed  Google Scholar 

  73. Ramtvedt BE, Sundet K (2014) Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial. Clin Neuropsychol 28:1146–1161

    Article  PubMed  Google Scholar 

  74. Wehmeier PM, Schacht A, Ulberstad F, Lehmann M, Schneider-Fresenius C, Lehmkuhl G, Dittmann RW, Banaschewski T (2012) Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology. J Clin Psychopharmacol 32:653–660

    Article  CAS  PubMed  Google Scholar 

  75. Gunther T, Kahraman-Lanzerath B, Knospe EL, Herpertz-Dahlmann B, Konrad K (2012) Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day. J Child Adolesc Psychopharmacol 22:131–138

    Article  PubMed  Google Scholar 

  76. Ramtvedt BE, Røinås E, Aabech HS, Sundet KS (2013) Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. J Child Adolesc Psychopharmacol 23:597–604

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The study was funded by the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC-EM). The research reported in this paper was also conducted by the NIHR MindTech Healthcare Technology Co-operative. This work has been funded by the National Institute for Health Research. The views represented are the views of the authors alone and do not necessarily represent the views of the Department of Health in England, NHS, or the National Institute for Health Research. The funding body had no role in the design, collection, analysis and interpretation of data, or in the writing of the manuscript.

Author information

Authors and Affiliations

  1. Division of Psychiatry and Applied Psychology, CLAHRC-EM, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK

    Charlotte L. Hall, Althea Z. Valentine, Gemma M. Walker & Chris Hollis

  2. Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK

    Madeleine J. Groom

  3. Developmental Psychiatry, School of Medicine, University of Nottingham, Nottingham, UK

    Kapil Sayal

  4. Centre for ADHD and Neuro-developmental Disorders Across the Lifespan (CANDAL), Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK

    Kapil Sayal & David Daley

  5. School of Medicine, University of Nottingham, Nottingham, UK

    David Daley

  6. Centre for ADHD and Neuro-developmental Disorders Across the Lifespan (CANDAL), University of Nottingham, Nottingham, UK

    Chris Hollis

  7. MindTech, Developmental Psychiatry, Queen’s Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK

    Chris Hollis

Authors
  1. Charlotte L. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Althea Z. Valentine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Madeleine J. Groom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gemma M. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kapil Sayal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Daley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chris Hollis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charlotte L. Hall.

Ethics declarations

Conflict of interests

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards

The paper is not a human or animal study so ethical approval was not required. However, all work was undertaken under the auspices of the AQUA-Trial, which has ethical approval.

Additional information

Charlotte L. Hall and Althea Z. Valentine are joint first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 54 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hall, C.L., Valentine, A.Z., Groom, M.J. et al. The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. Eur Child Adolesc Psychiatry 25, 677–699 (2016). https://doi.org/10.1007/s00787-015-0798-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-015-0798-x

Keywords

Search

Navigation